Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
This classic veterinary injectable is perfect for reducing liver disorders and boosting appetite in both small and large animals
Recommendations Start at 150 mcg
Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies
In laboratory studies, 5-Amino-1MQ has been evaluated for its interaction with nicotinamide N-methyltransferase (NNMT)-associated enzymatic pathways and downstream NAD+-related and methylation signaling under controlled experimental conditions
Further investigations using vascular endothelial cells suggested that BPC-157 might have increased mRNA and protein expressions of VEGFR2, but not VEGF-A
Tchoukalova, Y
US$ 24.59
US$ 23.51
US$ 24.80
US$ 23.59
